OraVerse Uses, Dosage, Side Effects and more

Trade Name OraVerse
Generic Phentolamine mesylate date of approval: may 9 + 2008 company: novalar pharmaceuticals + inc. treatment for: reversal of dental anesthesia
Type
Therapeutic Class
Manufacturer
Available Country United States,
Last Updated: January 7, 2025 at 1:49 am

Innovators Monograph


*** Taking medicines without doctor's advice can cause long-term problems.
Share